N-(5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl)-4-(phenylsulfonyl)butanamide

ID: ALA4445189

Chembl Id: CHEMBL4445189

PubChem CID: 155517641

Max Phase: Preclinical

Molecular Formula: C14H14FN3O4S

Molecular Weight: 339.35

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  O=C(CCCS(=O)(=O)c1ccccc1)Nc1nc(=O)[nH]cc1F

Standard InChI:  InChI=1S/C14H14FN3O4S/c15-11-9-16-14(20)18-13(11)17-12(19)7-4-8-23(21,22)10-5-2-1-3-6-10/h1-3,5-6,9H,4,7-8H2,(H2,16,17,18,19,20)

Standard InChI Key:  BSLGEAMUQRKZAR-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA4445189

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 339.35

Molecular Weight (Monoisotopic): 339.0689

AlogP: 1.10

#Rotatable Bonds: 6

Polar Surface Area: 108.99

Molecular Species: NEUTRAL

HBA: 5

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 7

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 7.80

CX Basic pKa: ┄

CX LogP: 0.09

CX LogD: -0.04

Aromatic Rings: 2

Heavy Atoms: 23

QED Weighted: 0.82

Np Likeness Score: -1.65

References

1. Hossain MA, Sattenapally N, Parikh HI, Li W, Rumbaugh KP, German NA..  (2020)  Design, synthesis, and evaluation of compounds capable of reducing Pseudomonas aeruginosa virulence.,  185  [PMID:31706639] [10.1016/j.ejmech.2019.111800]

Source

Source(1):

• Scientific Literature